The effects of vitamin D supplementation on inflammatory biomarkers in patients with abnormal glucose homeostasis: a systematic review and meta-analysis of randomized controlled trials.

[1]  S. Walrand,et al.  Effect of Vitamin D Supplementation on Inflammatory Markers in Non-Obese Lebanese Patients with Type 2 Diabetes: A Randomized Controlled Trial , 2020, Nutrients.

[2]  F. Rafiei,et al.  The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial. , 2020, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[3]  Sean M. Hartig,et al.  Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice , 2020, Hepatology.

[4]  L. Janani,et al.  Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 – A Randomized Clinical Trial , 2020, Complementary Medicine Research.

[5]  M. Clerici,et al.  Vitamin D Supplementation is Associated with Increased Glutathione Peroxidase-1 Levels in Arab Adults with Prediabetes , 2020, Antioxidants.

[6]  H. Poustchi,et al.  Soy isoflavones and cholecalciferol reduce inflammation, and gut permeability, without any effect on antioxidant capacity in irritable bowel syndrome: A randomized clinical trial. , 2019, Clinical nutrition ESPEN.

[7]  M. Djalali,et al.  Effects of vitamin D supplementation on advanced glycation end products signaling pathway in T2DM patients: a randomized, placebo-controlled, double blind clinical trial , 2019, Diabetology & Metabolic Syndrome.

[8]  J. Nelson,et al.  Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes. , 2019, Clinical nutrition.

[9]  K. Azizbeigi,et al.  Anti-inflammatory effects of vitamin D and resistance training in men with type 2 diabetes mellitus and vitamin D deficiency: a randomized, double-blinded, placebo-controlled clinical trial , 2019, Journal of Diabetes & Metabolic Disorders.

[10]  M. Jafarabadi,et al.  Vitamin D supplementation has no effect on matrix metalloproteinases-2, -9, and tissue inhibitor matrix metalloproteinase-1 in subjects with metabolic syndrome: A pilot study. , 2019, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[11]  Shi-kun Yang,et al.  Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropathy: a Systematic Review and Meta-Analysis , 2019, Kidney and Blood Pressure Research.

[12]  M. Vasson,et al.  Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial , 2019, Front. Immunol..

[13]  A. Rigby,et al.  A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome , 2019, Nutrients.

[14]  M. Mobasseri,et al.  The effects of vitamin D3 supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: A randomized double blind placebo controlled clinical trial. , 2019, Diabetes & metabolic syndrome.

[15]  S. Anton,et al.  Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis , 2018, Ageing Research Reviews.

[16]  R. Amani,et al.  The effects of supplementation with vitamin D on inflammatory biomarkers, omentin, and vaspin in women with type 2 diabetes: A randomized double‐blind placebo‐controlled clinical trial , 2018, Journal of Food Biochemistry.

[17]  Gang Huang,et al.  Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer , 2018, Cancer biology & therapy.

[18]  Guowei Huang,et al.  Effect of Vitamin D Supplementation on Some Inflammatory Biomarkers in Type 2 Diabetes Mellitus Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2018, Annals of Nutrition and Metabolism.

[19]  B. de Courten,et al.  Vitamin D supplementation for improvement of chronic low‐grade inflammation in patients with type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials , 2018, Nutrition reviews.

[20]  S. Chandrashekara,et al.  Effect of vitamin D supplementation on reduction of cardiometabolic risk in patients with type 2 diabetes mellitus and dyslipidemia , 2018, International Journal of Diabetes in Developing Countries.

[21]  F. Kolahdooz,et al.  The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2018, Hormone and Metabolic Research.

[22]  L. Janani,et al.  A double blind randomized clinical trial to investigate the effect of vitamin D supplementation on metabolic and hepato-renal markers in type 2 diabetes and obesity , 2018, Medical journal of the Islamic Republic of Iran.

[23]  M. Mazidi,et al.  Impact of vitamin D supplementation on C-reactive protein; a systematic review and meta-analysis of randomized controlled trials , 2018, BMC Nutrition.

[24]  B. de Courten,et al.  Effects of vitamin D supplementation on inflammatory markers in heart failure: a systematic review and meta-analysis of randomized controlled trials , 2018, Scientific Reports.

[25]  Y. Shang,et al.  Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF-κB signaling pathway , 2017, Molecular medicine reports.

[26]  Z. Asemi,et al.  Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome , 2017, Nutrients.

[27]  L. Janani,et al.  Can coenzyme Q10 supplementation effectively reduce human tumour necrosis factor-α and interleukin-6 levels in chronic diseases? Protocol for a systematic review and meta-analysis of randomised controlled trials , 2017, BMJ Open.

[28]  Z. Asemi,et al.  Note of Concern: Clinical Trial on the Effects of Vitamin D Supplementation on Metabolic Profiles in Diabetic Hemodialysis , 2018, Hormone and Metabolic Research.

[29]  Z. Asemi,et al.  The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial , 2017, Hormone and Metabolic Research.

[30]  M. Jafarabadi,et al.  The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial , 2017, Endocrine.

[31]  Yun Zhao,et al.  The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials , 2017, European Journal of Clinical Nutrition.

[32]  D. Dupont,et al.  Dairy products and inflammation: A review of the clinical evidence , 2017, Critical reviews in food science and nutrition.

[33]  R. Razzaghi,et al.  The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. , 2017, Journal of diabetes and its complications.

[34]  Ahmad Esmaillzadeh,et al.  Long-Term Vitamin D Supplementation Affects Metabolic Status in Vitamin D-Deficient Type 2 Diabetic Patients with Coronary Artery Disease. , 2017, The Journal of nutrition.

[35]  P. Bogdański,et al.  The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis , 2016, European Journal of Nutrition.

[36]  C. Catalano,et al.  No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial , 2016, BMC Medicine.

[37]  L. Rosella,et al.  Effect of Vitamin D3 Supplementation on Inflammatory Markers and Glycemic Measures among Overweight or Obese Adults: A Systematic Review of Randomized Controlled Trials , 2016, PloS one.

[38]  B. de Courten,et al.  Effect of vitamin D supplementation on inflammation: protocol for a systematic review , 2016, BMJ Open.

[39]  M. Tambuwala Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.

[40]  F. Siddiqui,et al.  A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: The DIMENSION trial , 2016, Diabetes & vascular disease research.

[41]  Wei-Long Jiang,et al.  Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta‐analysis of Randomized Controlled Trials , 2016, Clinical cardiology.

[42]  A. H. Rasool,et al.  Effects of 1α‐Calcidol (Alfacalcidol) on Microvascular Endothelial Function, Arterial Stiffness, and Blood Pressure in Type II Diabetic Nephropathy Patients , 2016, Microcirculation.

[43]  G. Hitman,et al.  Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double‐blind placebo‐controlled trial , 2016, Diabetes, obesity & metabolism.

[44]  Ahmad Esmaillzadeh,et al.  Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D‐deficient women with polycystic ovary syndrome: a randomized double‐blind placebo‐controlled clinical trial , 2015, Clinical endocrinology.

[45]  A. Slusher,et al.  A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention , 2015, Inflammation Research.

[46]  M. Uusitupa,et al.  Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study , 2015, Journal of diabetes research.

[47]  A. Goldfine,et al.  Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease. , 2015, Journal of diabetes and its complications.

[48]  S. Mousa,et al.  Effect of Vitamin D Supplementation on Glucose Control and Inflammatory Response in Type II Diabetes: A Double Blind, Randomized Clinical Trial , 2015, International journal of endocrinology and metabolism.

[49]  A. Sadiya,et al.  Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial , 2014, European Journal of Clinical Nutrition.

[50]  Ahmad Esmaillzadeh,et al.  Calcium-vitamin D cosupplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin D-insufficient diabetics: a randomized controlled clinical trial. , 2014, The Journal of clinical endocrinology and metabolism.

[51]  L. Rejnmark,et al.  Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. , 2014, Metabolism: clinical and experimental.

[52]  S. Ghavamzadeh,et al.  The Effect of Vitamin D Supplementation on Adiposity, Blood Glycated Hemoglobin, Serum Leptin and Tumor Necrosis Factor-α in Type 2 Diabetic Patients , 2014, International journal of preventive medicine.

[53]  O. Ryu,et al.  The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes , 2014, The Korean journal of internal medicine.

[54]  I. Njølstad,et al.  No Effect of High-Dose Vitamin D Supplementation on Glycemic Status or Cardiovascular Risk Factors in Subjects With Prediabetes , 2014, Diabetes Care.

[55]  M. Davidson,et al.  Effect of Long Term Vitamin D Supplementation on Biomarkers of Inflammation in Latino and African-American Subjects with Pre-Diabetes and Hypovitaminosis D , 2014, Hormone and Metabolic Research.

[56]  Zeng-li Zhang,et al.  Effect of Vitamin D Supplementation on the Level of Circulating High-Sensitivity C-Reactive Protein: A Meta-Analysis of Randomized Controlled Trials , 2014, Nutrients.

[57]  D. Agrawal,et al.  Vitamin D and inflammatory diseases , 2014, Journal of inflammation research.

[58]  J. Powell,et al.  Vitamin D and cardiovascular disease. , 2014, Circulation research.

[59]  M. Holick,et al.  Vitamin D and inflammation , 2014, Dermato-endocrinology.

[60]  M. Boaz,et al.  Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. , 2013, Clinical nutrition.

[61]  M. Dabbaghmanesh,et al.  Serum IL-18 and hsCRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes. , 2013, Iranian journal of immunology : IJI.

[62]  E. White,et al.  Lifestyle Factors and Inflammation: Associations by Body Mass Index , 2013, PloS one.

[63]  U. Querfeld Vitamin D and inflammation , 2013, Pediatric Nephrology.

[64]  Wei Li,et al.  25-hydroxyvitamin D3 ameliorates periodontitis by modulating the expression of inflammation-associated factors in diabetic mice , 2013, Steroids.

[65]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[66]  C. Aranow Vitamin D and the Immune System , 2011, Journal of Investigative Medicine.

[67]  Afsar U. Ahmed An overview of inflammation: mechanism and consequences , 2011, Frontiers in Biology.

[68]  L. Brennan,et al.  Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. , 2011, Molecular nutrition & food research.

[69]  N. Saidenberg-Kermanac’h,et al.  Vitamin D and inflammation. , 2010, Joint, bone, spine : revue du rhumatisme.

[70]  J. Coad,et al.  Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial , 2009, British Journal of Nutrition.

[71]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[72]  A. Pradhan,et al.  Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. , 2007, Nutrition reviews.

[73]  Jianfeng Xu,et al.  Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis , 2007, PloS one.

[74]  M. Holick Vitamin D deficiency. , 2007, The New England journal of medicine.

[75]  Raghu Kacker,et al.  Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.

[76]  S. Devaraj,et al.  ATVB In Focus Nutrition and Atherosclerosis , 2006 .

[77]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[78]  M. Rubio-Ruíz,et al.  Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. , 2015, Interdisciplinary topics in gerontology.

[79]  B. P. Gargari,et al.  Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency , 2012, Journal of Endocrinological Investigation.